Arbor Rapha Capital Bioholdings Corp I (ARCK) Financials
$11.90
$0.00 (0.00%)As on 10-Mar-2023 09:30EDT
Market cap
$257 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
--
|
--
|
10.90
|
5.11
|
1.33
|
1.05
|
|||||
|
Cost of Revenue
|
1.08
|
--
|
7.94
|
3.59
|
0.61
|
0.64
|
|||||
|
Gross Profit
|
-1.08
|
--
|
2.96
|
1.52
|
0.73
|
0.41
|
|||||
|
Operating Expenses
|
460,499.62
|
--
|
11.70
|
5.00
|
1.03
|
1.00
|
|||||
|
Operating Profit (EBIT)
|
-1.08
|
--
|
-0.80
|
0.11
|
0.30
|
0.05
|
|||||
|
Other Income
|
1.05
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-445,615.58
|
--
|
-0.32
|
0.41
|
-0.85
|
-0.47
|
|||||
|
Provision for Tax
|
0.16
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit after Tax (Net Income)
|
-445,615.74
|
--
|
-0.32
|
0.41
|
-0.85
|
-0.47
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
-0.96
|
-0.60
|
-0.28
|
0.34
|
-0.81
|
-0.43
|
Liabilities ($ Mln) |
TTM | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
-9.34
|
-0.01
|
-0.77
|
-0.81
|
-1.20
|
-0.43
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
10.35
|
0.01
|
--
|
--
|
--
|
--
|
|||||
|
Current Liabilities
|
0.77
|
0.00
|
4.08
|
1.24
|
1.50
|
1.19
|
|||||
|
Total Liabilities
|
2.55
|
0.18
|
16.83
|
0.67
|
0.37
|
0.86
|
Cashflow ($ Mln) |
TTM | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-0.93
|
0.48
|
0.25
|
-0.01
|
-0.06
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-212.18
|
-0.46
|
0.05
|
0.04
|
-0.10
|
|||||
|
Cash from Financing Activities
|
--
|
179.09
|
0.18
|
-0.20
|
0.02
|
0.16
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
Profitability Ratios |
TTM | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
--
|
40.83
|
-41.10
|
104.31
|
163.36
|
|||||
|
ROE (%)
|
--
|
--
|
40.83
|
-41.10
|
104.31
|
163.36
|
|||||
|
ROA (%)
|
-492,027.02
|
--
|
-3.70
|
79.50
|
-137.80
|
-48.09
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
-6.38
|
1.84
|
21.67
|
4.42
|
|||||
|
Net Margin (%)
|
-42,252,956.84
|
--
|
-2.97
|
8.10
|
-63.80
|
-44.75
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
1.13
|
2.83
|
0.27
|
0.47
|
|||||
|
EBIT Growth (%)
|
--
|
--
|
-838.78
|
-67.42
|
522.41
|
119.11
|
|||||
|
Net Profit Growth (%)
|
--
|
--
|
-178.27
|
148.64
|
-81.10
|
-99.51
|
|||||
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
-37,809.00
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Close Price ($)
|
10.12
|
9.95
|
1.13
|
1.60
|
1.91
|
0.60
|
|||||
|
High Price ($)
|
10.61
|
10.00
|
2.25
|
2.29
|
2.10
|
0.60
|
|||||
|
Low Price ($)
|
9.84
|
9.84
|
1.03
|
0.55
|
0.34
|
0.20
|
|||||
|
Market Cap ($ Cr)
|
256.59
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
-0.46
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
-0.01
|
-0.02
|
|||||
|
Current Ratio
|
1.65
|
5.88
|
0.32
|
0.35
|
0.16
|
0.18
|
|||||
|
Quick Ratio
|
1.65
|
--
|
0.27
|
0.31
|
0.13
|
0.18
|
|||||
|
Interest Coverage
|
--
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency Ratios |
TTM | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
6.41
|
4.62
|
10.99
|
19.98
|
|||||
|
Asset Turnover
|
--
|
--
|
1.25
|
9.82
|
2.16
|
1.07
|
|||||
|
Receivable days
|
--
|
--
|
15.66
|
13.67
|
48.79
|
50.59
|
|||||
|
Inventory Days
|
--
|
--
|
5.90
|
4.61
|
13.63
|
--
|
|||||
|
Payable days
|
--
|
--
|
52.09
|
71.00
|
410.77
|
325.57
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
-30.53
|
-52.72
|
-348.36
|
-274.98
|